Jump to content

Ashraf Brik

From Wikipedia, the free encyclopedia

Ashraf Brik
Born
Abu Snan, Israel
NationalityIsraeli
Alma materBen-Gurion University of the Negev, Technion
Scientific career
FieldsBiochemistry
InstitutionsTechnion, Scripps Research, Ben-Gurion University of the Negev

Ashraf Brik (Hebrew: אשרף בריק, Arabic: أشرف بريق;) is a full professor at the Schulich Faculty of Chemistry at the Technion Institute of Technology, Israel.[1] His laboratory specializes in developing synthetic methods for chemical synthesis of proteins with post-translational modifications (PTMs) in quantities that allow for them to be studied thoroughly. Brik's group is developing novel modulators based on small molecules, peptides and peptidomimetics, to influence enzymes (such as deubiquitinases) and proteins involved in various diseases. With the help of these tools, it is possible to understand how molecules and biological systems affect health.[2]

Early life and education

[edit]

Brik, one of ten children, was born and raised in Abu Snan in northern Israel. He received a bachelor's degree in chemistry from Ben-Gurion University of the Negev, a master's degree in chemistry from the Technion. He studied for his doctoral degree, in which he focused on research of chemical synthesis of proteins, from a joint course of the Technion and the Scripps Research Institute under the mentorship of Professor Chi-Huey Wong.[3] Brik authored the thesis “Design and Synthesis of Novel Catalytic Proteins Based on Polypeptide Scaffolds”, under the supervision of professor Ehud Keinan (Technion) and professor Phillip Dawson (The Scripps Research Institute).[4] He was promoted to senior researcher in 2004. He developed the synthesis of glycoproteins. In addition, Brik was involved in projects related to the discovery of inhibitors of various enzymes such as HIV protease.

Career

[edit]

In 2007 Brik joined the Department of Chemistry of Ben Gurion University of the Negev. In 2011 he was promoted to associate professor and in 2012 to full professor. In 2014, Brik moved to the Technion Institute of Technology, where he holds the Jordan and Irene Tark Chair. Brik has coauthored more than 120 publications in key periodicals: Science, Nature Chemistry, Nature Chemical Biology, Nature Protocols, Journal of the American Chemical Society, Angewandte Chemie, Chemical Society Reviews, Chemical Science and others.[5][6][7] Brik is a member of advisory and editing boards of a number of periodicals, including Cell Chemical Biology, ChemBioChem and Organic and Biomolecular Chemistry.[8][9] He has also registered 6 patents.[10]

The research efforts of Brik's group are budgeted by many foundations, including the European Commission's Horizon 2020 Program, which recently awarded him the ERC Advanced Grant.[11]

Research

[edit]

Posttranslational modification of proteins affects protein structure, function, stability and sub-cellular localization, making the process crucial to health and disease. Yet understanding the effects of these modifications at the molecular level has been hindered by the lack of homogeneously modified proteins obtained via traditional biochemical and molecular biology approaches. Moreover, the preparation of such complex bioconjugates at workable quantities is highly demanding. Recent advances in protein chemistry applying chemical and semisynthetic approaches are becoming increasingly beneficial to overcome these challenges. The Brik lab has been developing novel synthetic methods to prepare site-specifically modified proteins for biochemical, biophysical and functional analyses.[2]

The Brik group is one of world leaders in devising new methods to prepare ubiquitin-based conjugates necessary for detailed studies on ubiquitin signaling. Ubiquitination is the cellular process where the 76 amino acid ubiquitin protein, or a polyubiquitin chain, is linked to a protein target, affecting a variety of biological processes such as protein degradation, trafficking, transcription and the DNA damage response. Not surprisingly, ubiquitination plays a key role in various diseases, such as neurological disorders, infectious diseases and cancer.[12] In the face of challenges in producing ubiquitin conjugates using traditional molecular biology and enzymatic approaches, the Brik lab has developed a number of novel chemical methods for the preparation of large quantities of highly homogeneous and pure ubiquitin conjugates which have shed light on the mechanisms of ubiquitin signaling and enabled the discovery of novel modulators for the enzymes involved these processes.

Honors & Awards

[edit]
  • 2019: ERC Advanced Grant[11]
  • 2019: The ICI Prize for the Outstanding Scientist[13]
  • 2018: Elected member of the Young Israel Academy[14]
  • 2017: The Michael Bruno Memorial Award[15]
  • 2017: The Henry Taub Prize for Academic Excellence
  • 2015: Bessel Award of the Humboldt Foundation for 2015[16]
  • 2015: The 11th Hirata Award[17]
  • 2013: Teva Award for Excellence in memory of Eli Hurvitz[18]
  • 2013: The Tetrahedron Young Investigator Award in Bioorganic and Medicinal Chemistry for 2013[19]
  • 2013: Dean's Honors for Excellent Researcher (Faculty of Natural Sciences Ben-Gurion University)
  • 2012: Ben-Gurion University - Toronto prize for excellence in research[20]
  • 2011: The 2011 Israel Chemical Society prize for Outstanding Young Chemist[21]
  • 2009: Dean's Honors for Excellent Researcher (Faculty of Natural Sciences Ben-Gurion University)

Recent articles

[edit]
  • 2020: Examining the role of phosphorylation of p19 INK4d in its stability and ubiquitination using chemical protein synthesis. Muna Msallam, Hao Sun, Roman Meledin, Pauline Franz and Ashraf Brik. Chemical Science 2020, 11, 5526-5531
  • 2020: Gold (I)-Mediated Decaging or Cleavage of Propargylated Peptide Bond in Aqueous Conditions for Protein Synthesis and Manipulation. Muhammad Jbara, Emad Eid and Ashraf Brik. Journal of the American Chemical Society 142 (18), 8203-8210
  • 2020: Affinity Maturation of Macrocyclic Peptide Modulators of Lys48-linked Diubiquitin by a Twofold Strategy. Yichao Huang, Mickal Nawatha, Ido Livneh, Joseph M. Rogers, Hao Sun, Sumeet K. Singh, Aaron Ciechanover, Ashraf Brik and Hiroaki Suga. Chemistry–A European Journal
  • 2020: Total Chemical Synthesis of ISGylated-Ubiquitin Hybrid Chain Assisted by Acetamidomethyl Derivatives with Dual Functions. Emad Eid, Gabor Boross, Hao Sun, Muna Msallam, Sumeet Singh and Ashraf Brik. Bioconjugate chemistry 31 (3), 889-894
  • 2020: Examining Several Strategies for the Chemical Synthesis of Phosphorylated Histone H3 Reveals the Effectiveness of the Convergent Approach. Muhammad Jbara, Suman Kumar Maity and Ashraf Brik. Eur. J. Org. Chem. 2020, 3128–3132
  • 2019: The Journey for the Total Chemical Synthesis of a 53 kDa Protein. Hao Sun and Ashraf Brik. Accounts of chemical research 52 (12), 3361-3371
  • 2019: Palladium-Mediated Cleavage of Proteins with Thiazolidine-Modified Backbone in Live Cells. Guy Mann, Gandhesiri Satish, Roman Meledin, Ganga B. Vamisetti and Ashraf Brik. Angewandte Chemie International Edition 58 (38), 13540-13549
  • 2019: De novo macrocyclic peptides that specifically modulate Lys48-linked ubiquitin chains. Mickal Nawatha, Joseph Rogers, Steven M. Bonn, Ido Livneh, Betsegaw Lemma, Sachitanand M. Mali, Ganga B. Vamisetti, Hao Sun, Beatrice Bercovich, Yichao Huang, Aaron Ciechanover, David Fushman, Hiroaki Suga and Ashraf Brik. Nature chemistry 11 (7), 644-652
  • 2019: Mirroring Life's Building Blocks. Roman Meledin and Ashraf Brik. Cell chemical biology 26 (5), 616-619
  • 2019: Chemical Biology: Powerful Synergy Between Two Cultures. Ashraf Brik, Ehud Keinan. Israel Journal of Chemistry 59 (1-2), 3-6
  • 2019: Palladium-Mediated Direct Disulfide Bond Formation in Proteins Containing S-Acetamidomethyl-cysteine under Aqueous Conditions. Shay Laps, Hao Sun, Guy Kamnesky, Ashraf Brik. Angewandte Chemie International Edition 58 (17), 5729-5733
  • 2019: Semisynthesis of ubiquitinated histone H2B with a native or nonhydrolyzable linkage. Michael Morgana, Muhammad Jbarab, Ashraf Brik, Cynthia Wolberger. Methods in Enzymology Volume 618, 2019, Pages 1–27
  • 2019: Diverse fate of ubiquitin chain moieties: The proximal is degraded with the target, and the distal protects the proximal from removal and recycles. Hao Sun, Sachitanand Mali, Sumeet Singh, Roman Meledin, Ashraf Brik, Yong Tae Kwon, Yelena Kravtsova-Ivantsiv, Beatrice Bercovich, Aaron Ciechanover. Proceedings of the National Academy of Sciences 116 (16), 7805-7812
  • 2019: FACT and Ubp10 collaborate to modulate H2B deubiquitination and nucleosome dynamics. Melesse Nune, Michael T Morgan, Zaily Connell, Laura McCullough, Muhammad Jbara, Hao Sun, Ashraf Brik, Tim Formosa, Cynthia Wolberger. Elife 8, e40988
  • 2019: Halogen Substituents in the Isoquinoline Scaffold Switches the Selectivity of Inhibition between USP2 and USP7. Ganga B. Vamisetti, Roman Meledin, Pushparathinam Gopinath and Ashraf Brik. ChemBioChem 20 (2), 282-286

References

[edit]
  1. ^ Ashraf Brik's Laboratory, Technion
  2. ^ a b Ashraf Brik's Laboratory - Research Interests, Technion
  3. ^ Ashraf Brik's Laboratory - Biography & CV, Technion
  4. ^ Curriculum Vita and List of Publications (PDF), Ben Gurion University of the Negev, 2011
  5. ^ Author: Ashraf Brik, Nature
  6. ^ Morgan, Michael T.; Haj-Yahya, Mahmood; Ringel, Alison E.; Bandi, Prasanthi; Brik, Ashraf; Wolberger, Cynthia (2016), "Structural basis for histone H2B deubiquitination by the SAGA DUB module", Science, 351 (6274): 725–728, Bibcode:2016Sci...351..725M, doi:10.1126/science.aac5681, PMC 4863942, PMID 26912860, S2CID 206639559
  7. ^ Yang, Yu-Ying; Ficht, Simon; Brik, Ashraf; Wong, Chi-Huey (2017), "Sugar-Assisted Ligation in Glycoprotein Synthesis", Journal of the American Chemical Society, 129 (24), American Chemical Society: 7690–7701, doi:10.1021/ja0708971, PMC 2553000, PMID 17523644
  8. ^ Advisory Board, Cell Chemical Biology
  9. ^ Members of the Editorial Advisory Board, Chemistry Europe
  10. ^ "Ashraf Brik", Angewandte Chemie, 126 (7), Google Patents: 1766, 2014, Bibcode:2014AngCh.126.1766., doi:10.1002/ange.201308262
  11. ^ a b ERC Funded Projects, European Research Council, 2019
  12. ^ New Israeli-Japanese-American strategy could help eliminate cancer cells, The Jerusalem Post
  13. ^ The ICS Prize for the Outstanding Scientist, The Israel Chemical Society
  14. ^ Members - Prof. Ashraf Brik, The Israel Young Academy
  15. ^ Bruno Laureates - 2017, The Israel Institute for Advanced Studies
  16. ^ Positive selection decisions since March 2013: Friedrich Wilhelm Bessel Research Award, Alexander von Humboldt Foundation, archived from the original on 25 March 2019, retrieved 10 June 2020
  17. ^ The 11th Hirata Award, Nagoya University
  18. ^ Teva Award for Excellence received by Prof. Ashraf Brik, Ben-Gurion University of the Negev, 2013
  19. ^ Tetrahedron Young Inversitgator 2013: Prof. Brik, ScienceDirect
  20. ^ BGU recognizes Outstanding Lecturers and Researchers, Ben-Gurion University of the Negev, 2012
  21. ^ The ICS prize for Outstanding Young Chemist, The Israel Chemical Society
[edit]
Retrieved from "https://wiki.riteme.site/w/index.php?title=Ashraf_Brik&oldid=1255323516"